CoMPAS (Inflammatory Bowel Disease)

CoMPAS (Inflammatory Bowel Disease)

Es posible que algunos contenidos no estén disponibles en español.

Purpose of this Study

We are doing this study to identify new signs and symptoms of inflammatory bowel disease (IBD) in children and young adults. We want to improve at predicting the future course of IBD so that we can treat it better and faster. We also hope this study will help us learn how IBD develops so that we can make new treatments for IBD.

Who Can Participate?

Eligibility

Children and adults ages 2-21 who:
  • Are referred by their doctor to have a colonoscopy and biopsy
  • Are suspected to have IBD or have been diagnosed with IBD in the past 2 years
  • Were not using any medications or supplements for IBD prior to diagnosis
For more information, contact the study team at alex.hammett@duke.edu.

Age Range

2-21

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

Description

If you choose to join this study, you will have extra biopsies taken from 3 different parts of you intestine. This will be done at the same time that your doctor is taking routine samples during your regular endoscopy procedure that's part of your normal clinical care.

Locations

Duke University Hospital

Visit Timing

Weekdays

Compensation

Yes

Spanish Materials Available

Yes

Study Details

Full Title

Crohn's Machine Learning Predictions and Single Cell Analysis (CoMPAS) - DUHS IRB-sIRB

Principal Investigator

Sana
Syed

Protocol Number

PRO00117942

Phase

0

Enrollment Status

Pending Open to Enrollment